Clinical Trial Update: TOFACITINIB vs TOFACITINIB WITH MESALAMINE IN ULCERATIVE COLITIS [Phase 4]

View source ↗

Summary

This document notes a Phase 4 clinical trial comparing tofacitinib alone versus tofacitinib with mesalamine in ulcerative colitis, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Mesalamine (Mesalamine)
• Tofacitinib (tofacitinib)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Ulcerative Colitis | Phase 4 | Status: NOT_YET_RECRUITING